Bone Grafts Research Today is a free monthly online journal that collates and summarizes the latest research about Bone Grafts, including details on spine fusion, surgery, procedure, risks.

Volume 7 (2010), Issue 1 (January)

1. Autologous bone marrow mesenchymal cell transplantation improves left ventricular function in a rabbit model of dilated cardiomyopathy.
   Exp Mol Pathol. [Abstract] [Full-text]
2. The use of a biodegradable mesh plate to augment grafting of an acetabular defect: Laboratory investigation and clinical pilot study.
   J Bone Joint Surg Br, 92(1): 179-85. [Abstract] [Full-text]
3. A regenerative strategy for heart failure in hypoplastic left heart syndrome: Intracoronary administration of autologous bone marrow-derived progenitor cells.
   J Heart Lung Transplant. [Abstract] [Full-text]
4. Treatment of locked chronic posterior dislocation of the shoulder by reconstruction of the defect in the humeral head with an allograft.
   J Bone Joint Surg Br, 92(1): 71-6. [Abstract] [Full-text]
5. "Skip" corpectomy in the treatment of multilevel cervical spondylotic myelopathy and ossified posterior longitudinal ligament.
   J Neurosurg Spine, 12(1): 33-8. [Abstract] [Full-text]
6. Glycoprotein 130-dependent pathways in host hepatocytes are important for liver repopulation in mice.
   Liver Transpl, 16(1): 23-32. [Abstract] [Full-text]
7. Fibroblasts/myofibroblasts that participate in cutaneous wound healing are not derived from circulating progenitor cells.
   J Cell Physiol, 222(3): 703-12. [Abstract] [Full-text]
8. Upregulation of heme oxygenase-1 inhibits the maturation and mineralization of osteoblasts.
   J Cell Physiol, 222(3): 757-68. [Abstract] [Full-text]
9. Bone marrow transplantation results in human donor blood cells acquiring and displaying mouse recipient class I MHC and CD45 antigens on their surface.
   PLoS One, 4(12): e8489. [Abstract] [Full-text]
10. Effects of polycaprolactone-tricalcium phosphate, recombinant human bone morphogenetic protein-2 and dog mesenchymal stem cells on bone formation: pilot study in dogs.
    Yonsei Med J, 50(6): 825-31. [Abstract] [Full-text]
11. Abnormal immunity and stem/progenitor cells in acquired aplastic anemia.
    Crit Rev Oncol Hematol. [Abstract] [Full-text]
12. The in vivo performance of bioartificial pancreas in bone marrow cavity: A case report of a spontaneous diabetic feline.
    Biochem Biophys Res Commun. [Abstract] [Full-text]
13. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.
    Eur J Immunol, 40(1): 22-35. [Abstract] [Full-text]
14. Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats.
    J Cereb Blood Flow Metab, 30(1): 140-9. [Abstract] [Full-text]
15. Interleukin-7 receptor-alpha gene polymorphisms in bone marrow transplant recipients.
    Mol Biol Rep, 37(1): 27-31. [Abstract] [Full-text]
16. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody.
    Circulation, 121(1): 80-90. [Abstract] [Full-text]
17. Autologous bone graft versus demineralized bone matrix in internal fixation of ununited long bones.
    J Trauma Manag Outcomes, 3: 11. [Abstract] [Full-text]
18. Novel nanostructured scaffold for osteochondral regeneration: pilot study in horses.
    J Tissue Eng Regen Med. [Abstract] [Full-text]
19. Intramedullary Cavity as an Implant Site for Bioartificial Pancreas: An In Vivo Study on Diabetic Canine.
    Transplantation. [Abstract] [Full-text]
20. Reconstruction of major traumatic segmental bone defects of the tibia with vascularized bone transfers.
    Plast Reconstr Surg, 125(1): 215-23. [Abstract] [Full-text]
21. Fibula free flap reconstruction of the pelvisin children after limb-sparing internal hemipelvectomy for bone sarcoma.
    Plast Reconstr Surg, 125(1): 195-200. [Abstract] [Full-text]
22. Disease modeling in zebrafish: cancer and immune responses-a report on a workshop held in Spoleto, Italy, July 20-22, 2009.
    Zebrafish, 6(4): 445-51. [Abstract] [Full-text]
23. MMP-8 promotes polymorphonuclear cell migration through collagen barriers in obliterative bronchiolitis.
    J Leukoc Biol, 87(1): 69-77. [Abstract] [Full-text]
24. The lupus susceptibility locus Sle3 is not sufficient to accelerate atherosclerosis in lupus-susceptible low density lipoprotein receptor-deficient mice.
    Lupus, 19(1): 34-42. [Abstract] [Full-text]
25. HSV-1 viremia as a potential cause of febrile neutropenia in an immunocompromised child.
    J Pediatr Hematol Oncol, 32(1): e19-21. [Abstract] [Full-text]
26. Microendoscopic Anterior Approach for Irreducible Atlantoaxial Dislocation: Surgical Techniques and Preliminary Results.
    J Spinal Disord Tech. [Abstract] [Full-text]
27. Cryopreservation of Autologous Bone Grafts: An Experimental Study on a Sheep Animal Model.
    Cells Tissues Organs. [Abstract] [Full-text]
28. Hurler syndrome: a case report of a 5-year follow-up of dental findings after bone marrow transplantation.
    Spec Care Dentist, 30(1): 14-7. [Abstract] [Full-text]
29. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction.
    J Clin Invest, 120(1): 142-56. [Abstract] [Full-text]
30. The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.
    J Clin Invest, 120(1): 343-56. [Abstract] [Full-text]
31. Intra-bone marrow bone marrow transplantation rejuvenates the B-cell lineage in aged mice.
    Immunol Cell Biol, 88(1): 87-94. [Abstract] [Full-text]
32. Transplantation of unrelated donor umbilical cord blood for nonmalignant diseases: a single institution's experience with 45 patients.
    Biol Blood Marrow Transplant, 16(1): 102-7. [Abstract] [Full-text]
33. STAT3 signaling in CD4+ T cells is critical for the pathogenesis of chronic sclerodermatous graft-versus-host disease in a murine model.
    J Immunol, 184(2): 764-74. [Abstract] [Full-text]
34. Shedding of the endothelial receptor tyrosine kinase Tie2 correlates with leukemic blast burden and outcome after allogeneic hematopoietic stem cell transplantation for AML.
    Ann Hematol. [Abstract] [Full-text]
35. Osteogenic Differentiation Capacity of Porcine Dental Follicle Progenitor Cells.
    Connect Tissue Res. [Abstract] [Full-text]
36. Hemoglobinuria and acute kidney injury requiring hemodialysis following intravenous immunoglobulin infusion.
    Am J Kidney Dis, 55(1): 148-51. [Abstract] [Full-text]
37. The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL.
    Blood, 115(1): 71-7. [Abstract] [Full-text]
38. Soluble lymphotoxin is an important effector molecule in GVHD and GVL.
    Blood, 115(1): 122-32. [Abstract] [Full-text]
39. Tolerogenic Dendritic Cells: All Present and Correct?
    Am J Transplant. [Abstract] [Full-text]
40. 3D PLGA scaffolds improve differentiation and function of bone marrow mesenchymal stem cell-derived hepatocytes.
    Stem Cells Dev. [Abstract] [Full-text]
41. Comparison of revision rates in bone-patella tendon-bone autograft and allograft anterior cruciate ligament reconstruction.
    Orthopedics, 33(1): 12. [Abstract] [Full-text]
42. Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting.
    Blood, 115(1): 107-21. [Abstract] [Full-text]
43. Xenogenic transplantation of human mesenchymal stem cells in a critical size defect of the sheep tibia for bone regeneration.
    Tissue Eng Part A, 16(1): 33-43. [Abstract] [Full-text]
44. Bone grafts engineered from human adipose-derived stem cells in perfusion bioreactor culture.
    Tissue Eng Part A, 16(1): 179-89. [Abstract] [Full-text]
45. Hypoxic preconditioning of human mesenchymal stem cells overcomes hypoxia-induced inhibition of osteogenic differentiation.
    Tissue Eng Part A, 16(1): 153-64. [Abstract] [Full-text]
46. Comparing pediatric deaths with and without hospice support.
    Pediatr Blood Cancer. [Abstract] [Full-text]
47. Delayed administration of filgrastim (G-CSF) following autologous peripheral blood stem cell transplantation (APBSCT) in pediatric patients does not change time to neutrophil engraftment and reduces use of G-CSF.
    Pediatr Blood Cancer. [Abstract] [Full-text]
48. The impact of KIR2DS4 alleles and the expression of KIR in the development of acute GVHD after unrelated allogeneic hematopoietic SCT.
    Bone Marrow Transplant. [Abstract] [Full-text]
49. A comparative assessment of the RIFLE, AKIN and conventional criteria for acute kidney injury after hematopoietic SCT.
    Bone Marrow Transplant. [Abstract] [Full-text]
50. Retrospective comparison of the effects of filgrastim and pegfilgrastim on the pace of engraftment in auto-SCT patients.
    Bone Marrow Transplant. [Abstract] [Full-text]
51. Regression modeling of competing risk using R: an in depth guide for clinicians.
    Bone Marrow Transplant. [Abstract] [Full-text]
52. HLA-mismatched hematopoietic SCT without in vitro T-cell depletion for myelodysplastic syndrome.
    Bone Marrow Transplant. [Abstract] [Full-text]
53. HLA-matched sibling transplantation with BM and CD34(+)-purified PBSCs in adult patients with high-risk severe aplastic anemia to overcome graft rejection without an increase in GVHD.
    Bone Marrow Transplant. [Abstract] [Full-text]
54. Etoposide induces more severe mucositis than CY when added to TBI as conditioning in allograft recipients receiving CsA and MTX.
    Bone Marrow Transplant. [Abstract] [Full-text]
55. Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center.
    Bone Marrow Transplant. [Abstract] [Full-text]
56. Hematopoietic SCT in children with Griscelli syndrome: a single-center experience.
    Bone Marrow Transplant. [Abstract] [Full-text]
57. Improved outcome in relapsed and refractory myeloid malignancies for unrelated vs related donor allogeneic peripheral blood-derived hematopoietic cell transplantation.
    Bone Marrow Transplant. [Abstract] [Full-text]
58. Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study.
    Bone Marrow Transplant. [Abstract] [Full-text]
59. Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia.
    Bone Marrow Transplant. [Abstract] [Full-text]
60. Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT.
    Bone Marrow Transplant. [Abstract] [Full-text]
61. Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Bone Marrow Transplant. [Abstract] [Full-text]
62. Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma.
    Bone Marrow Transplant. [Abstract] [Full-text]
63. Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT.
    Bone Marrow Transplant. [Abstract] [Full-text]
64. A strong association between respiratory viral infection early after HSCT and the development of life threatening acute and chronic alloimmune lung syndromes.
    Biol Blood Marrow Transplant. [Abstract] [Full-text]
65. Distinct requirements for achievement of allotolerance versus reversal of autoimmunity via nonmyeloablative mixed chimerism induction in NOD mice.
    Transplantation, 89(1): 23-32. [Abstract] [Full-text]
66. Reconstitution of self-tolerance after hematopoietic stem cell transplantation.
    Immunol Res. [Abstract] [Full-text]
67. Comparison between bovine bone and titanium interference screws for implant fixation in ACL reconstruction: a biomechanical study.
    Arch Orthop Trauma Surg. [Abstract] [Full-text]
68. Immediate Plate Osteosynthesis of Open Fractures of the Humeral Shaft.
    J Trauma. [Abstract] [Full-text]
69. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells.
    Blood. [Abstract] [Full-text]
70. Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adults.
    Haematologica, 95(1): 79-86. [Abstract] [Full-text]
71. Challenges in the treatment of femoral neck fractures in the nonelderly adult.
    J Trauma, 68(1): 236-42. [Abstract] [Full-text]
72. Medial gastrocnemius muscle flap for treating wound complications after double-plate fixation via two-incision approach for complex tibial plateau fractures.
    J Trauma, 68(1): 138-45. [Abstract] [Full-text]
73. Combined injury: factors with potential to impact radiation dose assessments.
    Health Phys, 98(2): 145-52. [Abstract] [Full-text]
74. High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study.
    Bone Marrow Transplant, 45(1): 79-85. [Abstract] [Full-text]
75. Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles.
    Leukemia, 24(1): 58-65. [Abstract] [Full-text]
76. In vivo dynamics of human cord blood-derived CD34(-) SCID-repopulating cells using intra-bone marrow injection.
    Leukemia, 24(1): 162-8. [Abstract] [Full-text]
77. Liver transplantation exceeding UCSF criteria: case report of a late recurrence treated by surgery and review of the literature.
    Eur Surg Res, 44(1): 52-5. [Abstract] [Full-text]
78. Muscle resident macrophages control the immune cell reaction in a mouse model of notexin-induced myoinjury.
    Arthritis Rheum, 62(1): 268-79. [Abstract] [Full-text]
79. Primary Pituitary Lymphoma: Idiopathic Anasarca with Relapse in Bone Marrow Only.
    Acta Haematol, 123(2): 121-125. [Abstract] [Full-text]
80. Donor and recipient chemokine receptor CCR5 genotype is associated with survival after bone marrow transplantation.
    Blood. [Abstract] [Full-text]
81. Therapeutic potential of adipose-derived stem cells in vascular growth and tissue repair.
    Curr Opin Organ Transplant, 15(1): 86-91. [Abstract] [Full-text]
82. Development and Function of Myeloid-Derived Suppressor Cells Generated from Mouse Embryonic and Hematopoietic Stem Cells.
    Stem Cells. [Abstract] [Full-text]
83. Transmyocardial laser revascularization combined with intramyocardial endothelial progenitor cell transplantation in patients with intractable ischemic heart disease ineligible for conventional revascularization: preliminary results in a highly selected small patient cohort.
    Thorac Cardiovasc Surg, 58(1): 11-6. [Abstract] [Full-text]
84. Failure of interferon gamma to induce the anti-inflammatory interleukin 18 binding protein in familial hemophagocytosis.
    PLoS One, 5(1): e8663. [Abstract] [Full-text]
85. Optimal microvessel density from composite graft of autogenous maxillary cortical bone and anorganic bovine bone in sinus augmentation: influence of clinical variables.
    Clin Oral Implants Res, 21(2): 221-7. [Abstract] [Full-text]
86. Vascularized bone grafts within composite tissue allotransplants can auto-create tolerance via mixed chimerism with partial myeloablative conditioning: an experimental study in rats.
    Plast Reconstr Surg. [Abstract] [Full-text]
87. Transfacetal Fusion for Low-grade Degenerative Spondylolisthesis of the Lumbar Spine: Results of a Prospective Single Center Study.
    J Spinal Disord Tech. [Abstract] [Full-text]
88. Platelet transfusion refractoriness in highly immunized beta thalassemia children undergoing stem cell transplantation.
    Pediatr Transplant. [Abstract] [Full-text]
89. Postoperative surveillance with monthly serum tumor markers after living-donor liver transplantation for hepatocellular carcinoma.
    Hepatol Res. [Abstract] [Full-text]
90. Prospects for osteoprogenitor stem cells in fracture repair and osteoporosis.
    Curr Opin Organ Transplant, 15(1): 73-8. [Abstract] [Full-text]
91. Salvage of failed acetabular cages by nonbuttressed trabecular metal cups.
    Clin Orthop Relat Res, 468(2): 466-71. [Abstract] [Full-text]
92. Congenic interval of CD45/Ly-5 congenic mice contains multiple genes that may influence hematopoietic stem cell engraftment.
    Blood, 115(2): 408-17. [Abstract] [Full-text]
93. Pre-transplant lung function is predictive of survival following pediatric bone marrow transplantation.
    Pediatr Blood Cancer, 54(3): 454-60. [Abstract] [Full-text]
94. Free vascularized fibular graft reconstruction of large skeletal defects after tumor resection.
    Clin Orthop Relat Res, 468(2): 590-8. [Abstract] [Full-text]
95. Impaction bone grafting in revision hip surgery: past, present and future.
    Cell Tissue Bank, 11(1): 57-73. [Abstract] [Full-text]
96. Pregnancy in a woman with polycystic ovary syndrome and myelodysplastic syndrome (in the form of refractory anemia) treated with allogeneic hemopoietic stem-cell transplantation (alloHSCT).
    Gynecol Endocrinol, 26(2): 135-8. [Abstract] [Full-text]
97. Quantification of busulfan in plasma using liquid chromatography electrospray tandem mass spectrometry (HPLC-ESI-MS/MS).
    Methods Mol Biol, 603: 129-36. [Abstract] [Full-text]
98. Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donors.
    Blood. [Abstract] [Full-text]
99. Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy.
    Clin Cancer Res, 16(2): 727-35. [Abstract] [Full-text]
100. A three-dimensional method for evaluating changes in acetabular osteolytic lesions in response to treatment.
     Clin Orthop Relat Res, 468(2): 480-90. [Abstract] [Full-text]
101. Intra-bone marrow transplantation of human CD34(+) cells into NOD/LtSz-scid IL-2rgamma(null) mice permits multilineage engraftment without previous irradiation.
     Cytotherapy, 12(1): 45-9. [Abstract] [Full-text]
102. Sinus Floor Augmentation Surgery Using Autologous Bone Grafts from Various Donor Sites: A Meta-Analysis of the Total Bone Volume.
     Tissue Eng Part B Rev. [Abstract] [Full-text]
103. IL-17-producing T cells can augment autoantibody-induced arthritis.
     Proc Natl Acad Sci U S A, 106(51): 21789-94. [Abstract] [Full-text]
104. Conditional c-myb knockout in adult hematopoietic stem cells leads to loss of self-renewal due to impaired proliferation and accelerated differentiation.
     Proc Natl Acad Sci U S A, 106(51): 21689-94. [Abstract] [Full-text]
105. bFGF-Modified BMMSCs enhance bone regeneration following distraction osteogenesis in rabbits.
     Bone. [Abstract] [Full-text]
106. Immunomodulatory effects of vitamin D: implications for GVHD.
     Bone Marrow Transplant. [Abstract] [Full-text]
107. Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenstrom's macroglobulinemia. Results of a retrospective analysis of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire.
     Haematologica. [Abstract] [Full-text]
108. Allogeneic stem cell transplantation using myeloablative and reduced intensity conditioning in patients with Major Histocompatibility Complex class II deficiency.
     Biol Blood Marrow Transplant. [Abstract] [Full-text]
109. Safety and efficacy of granulocyte-colony-stimulating factor administration following autologous intramuscular implantation of bone marrow mononuclear cells: a randomized controlled trial in patients with advanced lower limb ischemia.
     Cytotherapy. [Abstract] [Full-text]
110. Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner.
     Cytotherapy. [Abstract] [Full-text]
111. Dermal fibroblast-mediated BMP2 therapy to accelerate bone healing in an equine osteotomy model.
     J Orthop Res, 28(3): 403-11. [Abstract] [Full-text]
112. Enhanced healing of goat femur-defect using BMP7 gene-modified BMSCs and load-bearing tissue-engineered bone.
     J Orthop Res, 28(3): 412-8. [Abstract] [Full-text]
113. Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function.
     Stem Cells, 28(1): 140-51. [Abstract] [Full-text]
114. Invasive aspergillosis presenting with a painless complete ophthalmoplegia.
     Clin Neurol Neurosurg, 112(1): 85-7. [Abstract] [Full-text]
115. The negative co-signaling molecule b7-h4 is expressed by human bone marrow-derived mesenchymal stem cells and mediates its T-cell modulatory activity.
     Stem Cells Dev, 19(1): 27-38. [Abstract] [Full-text]
116. Enhanced hematovascular contribution of SCL 3' enhancer expressing fetal liver cells uncovers their potential to integrate in extramedullary adult niches.
     Stem Cells, 28(1): 100-12. [Abstract] [Full-text]
117. Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study).
     Eur J Heart Fail, 12(2): 172-80. [Abstract] [Full-text]
118. Scaffold-free cell sheet injection results in bone formation.
     J Tissue Eng Regen Med. [Abstract] [Full-text]
119. Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT.
     Radiographics, 30(1): 127-42. [Abstract] [Full-text]
120. Glomerulonephritis after hematopoietic cell transplantation: IgA nephropathy with increased excretion of galactose-deficient IgA1.
     Nephrol Dial Transplant. [Abstract] [Full-text]
121. Role of CCR7 in facilitating direct allosensitization and regulatory T-cell function in high-risk corneal transplantation.
     Invest Ophthalmol Vis Sci, 51(2): 816-21. [Abstract] [Full-text]
122. Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin's lymphoma.
     Ann Hematol, 89(3): 263-72. [Abstract] [Full-text]
123. Differential Effect of Scaffold Shape on Dentin Regeneration.
     Ann Biomed Eng. [Abstract] [Full-text]
124. Platelet-derived thrombospondin-1 (TSP-1) is a critical negative regulator and potential biomarker of angiogenesis.
     Blood. [Abstract] [Full-text]
125. Mimicking the haematopoietic niche microenvironment provides a novel strategy for expansion of haematopoietic and megakaryocyte-progenitor cells from cord blood.
     Br J Haematol. [Abstract] [Full-text]
126. Access with evidence development: the US experience.
     Pharmacoeconomics, 28(2): 153-62. [Abstract] [Full-text]
127. Timing of bone marrow cell delivery has minimal effects on cell viability and cardiac recovery after myocardial infarction.
     Circ Cardiovasc Imaging, 3(1): 77-85. [Abstract] [Full-text]
128. Hepatocyte growth factor-mediated attraction of mesenchymal stem cells for apoptotic neuronal and cardiomyocytic cells.
     Cell Mol Life Sci, 67(2): 295-303. [Abstract] [Full-text]
129. Cyclosporine A-induced neck fibrosis in a patient with adult-onset Still's disease.
     Clin Rheumatol, 29(2): 205-8. [Abstract] [Full-text]
130. Surgical treatment of grade I central chondrosarcoma.
     Clin Orthop Relat Res, 468(2): 581-9. [Abstract] [Full-text]
131. Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors.
     J Cancer Res Clin Oncol, 136(1): 165-7. [Abstract] [Full-text]
132. Individualized therapy to prevent bone mineral density loss after kidney and kidney-pancreas transplantation.
     Clin J Am Soc Nephrol, 5(1): 117-24. [Abstract] [Full-text]
133. Successful treatment of refractory advanced nasal NK/T cell lymphoma with unrelated cord blood stem cell transplantation incorporating focal irradiation.
     Int J Hematol, 91(1): 107-11. [Abstract] [Full-text]
134. Successful unrelated bone marrow transplantation for a human immunodeficiency virus type-1-seropositive acute myelogenous leukemia patient following HAART.
     Int J Hematol, 91(1): 140-5. [Abstract] [Full-text]
135. HO-1 gene overexpression enhances the beneficial effects of superparamagnetic iron oxide labeled bone marrow stromal cells transplantation in swine hearts underwent ischemia/reperfusion: an MRI study.
     Basic Res Cardiol. [Abstract] [Full-text]
136. Influenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation: a potentially catastrophic problem in a vulnerable population.
     Int J Hematol, 91(1): 124-7. [Abstract] [Full-text]
137. Single-stage closing-opening wedge osteotomy of spine to correct severe post-tubercular kyphotic deformities of the spine: a 3-year follow-up of 17 patients.
     Eur Spine J. [Abstract] [Full-text]
138. BMP-2/PLGA Delayed-Release Microspheres Composite Graft, Selection of Bone Particulate Diameters, and Prevention of Aseptic Inflammation for Bone Tissue Engineering.
     Ann Biomed Eng. [Abstract] [Full-text]
139. BMP depletion occurs during prolonged acid demineralization of bone: characterization and implications for graft preparation.
     Cell Tissue Bank. [Abstract] [Full-text]
140. In vivo outcomes of tissue-engineered osteochondral grafts.
     J Biomed Mater Res B Appl Biomater. [Abstract] [Full-text]
141. Effect of cyclosporine on blood pressure.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
142. Serotonin receptor antagonists for highly emetogenic chemotherapy in adults.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
143. Intravenous delivery of bone marrow-derived endothelial progenitor cells improves survival and attenuates lipopolysaccharide-induced lung injury in rats.
     Shock. [Abstract] [Full-text]
144. Expression of soluble Nogo-66 receptor and brain-derived neurotrophic factor in transduced rat bone marrow stromal cells.
     J Clin Neurosci. [Abstract] [Full-text]
145. Case report: Fresh-stored osteochondral allograft for treatment of osteochondritis dissecans the femoral head.
     Clin Orthop Relat Res, 468(2): 613-8. [Abstract] [Full-text]
146. Recruitment and differentiation of conventional dendritic cell precursors in tumors.
     J Immunol, 184(3): 1261-7. [Abstract] [Full-text]
147. Loss of CD34 leads to exacerbated autoimmune arthritis through increased vascular permeability.
     J Immunol, 184(3): 1292-9. [Abstract] [Full-text]
148. Cord blood and bone marrow transplantation in inherited metabolic diseases: scientific basis, current status and future directions.
     Br J Haematol, 148(3): 356-72. [Abstract] [Full-text]
149. Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR).
     Br J Haematol, 148(3): 386-93. [Abstract] [Full-text]
150. Treatment of osteochondral lesions of the talus: a systematic review.
     Knee Surg Sports Traumatol Arthrosc, 18(2): 238-46. [Abstract] [Full-text]
151. In vivo cellular imaging pinpoints the role of reactive oxygen species in the early steps of adult hematopoietic reconstitution.
     Blood, 115(3): 443-52. [Abstract] [Full-text]
152. Effect of MCI-196 on serum phosphate and cholesterol levels in haemodialysis patients with hyperphosphataemia: a double-blind, randomized, placebo-controlled study.
     Nephrol Dial Transplant, 25(2): 574-81. [Abstract] [Full-text]
153. Imaging of anterior cruciate ligament repair and its complications.
     AJR Am J Roentgenol, 194(2): 476-84. [Abstract] [Full-text]
154. Lack of Mitogen-Activated Protein Kinase Phosphatase-1 Protects ApoE-Null Mice Against Atherosclerosis.
     Circ Res. [Abstract] [Full-text]
155. B-cell-specific lentiviral gene therapy leads to sustained B cell functional recovery in a murine model of X-linked agammaglobulinemia.
     Blood. [Abstract] [Full-text]
156. Multiple myeloma treatment response assessment with whole-body dynamic contrast-enhanced MR imaging.
     Radiology, 254(2): 521-31. [Abstract] [Full-text]
157. Defects in the leukocyte adhesion cascade.
     Clin Rev Allergy Immunol, 38(1): 54-60. [Abstract] [Full-text]
158. Chronic granulomatous disease.
     Clin Rev Allergy Immunol, 38(1): 3-10. [Abstract] [Full-text]
159. Do bone grafts or barrier membranes provide additional treatment effects for infrabony lesions treated with enamel matrix derivatives? A network meta-analysis of randomized-controlled trials.
     J Clin Periodontol, 37(1): 59-79. [Abstract] [Full-text]
160. Methylation status of nine tumor suppressor genes in multiple myeloma.
     Int J Hematol, 91(1): 87-96. [Abstract] [Full-text]
161. Molecular signatures of quiescent, mobilized and leukemia-initiating hematopoietic stem cells.
     PLoS One, 5(1): e8785. [Abstract] [Full-text]
162. Hedgehog promotes neovascularization in pancreatic cancers by regulating Ang-1 and IGF-1 expression in bone-marrow derived pro-angiogenic cells.
     PLoS One, 5(1): e8824. [Abstract] [Full-text]
163. Toxicity of high-dose chemotherapy with etoposide, thiotepa and CY in treating poor-prognosis Ewing's sarcoma family tumors: the experience of the Bambino Gesù Children's Hospital.
     Bone Marrow Transplant. [Abstract] [Full-text]
164. CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function.
     Bone Marrow Transplant. [Abstract] [Full-text]
165. Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience.
     Bone Marrow Transplant. [Abstract] [Full-text]
166. Investigation of murine spleen as a niche for hematopoiesis.
     Transplantation, 89(2): 140-5. [Abstract] [Full-text]
167. Combined use of platelet-rich plasma and autologous bone grafts in the treatment of long bone defects in mini-pigs.
     Injury. [Abstract] [Full-text]
168. Serial bone marrow transplantation reveals in vivo expression of the pCLPG retroviral vector.
     Virol J, 7(1): 16. [Abstract] [Full-text]
169. Committed osteoclast precursors colonize the bone and improve the phenotype of a mouse model of autosomal recessive osteopetrosis.
     J Bone Miner Res, 25(1): 106-113. [Abstract] [Full-text]
170. Impact of growth factors and PTHrP on early and late chondrogenic differentiation of human mesenchymal stem cells.
     J Cell Physiol, 223(1): 84-93. [Abstract] [Full-text]
171. Bone Marrow Cell Cotransplantation With Islets Improves Their Vascularization and Function.
     Transplantation. [Abstract] [Full-text]
172. Quantitative Ultrasound detects Bone Changes following Bone Marrow Transplantation in Pediatric Subjects affected with Hematological Diseases: a longitudinal study.
     J Endocrinol Invest. [Abstract] [Full-text]
173. Meta-Analysis Shows that Detection of Circulating Tumor Cells Indicates Poor Prognosis in Patients with Colorectal Cancer.
     Gastroenterology. [Abstract] [Full-text]
174. Modulating T cell functions does not alleviate chronic inflammatory skin lesions in K5.TGFbeta1 transgenic mice.
     Exp Dermatol. [Abstract] [Full-text]
175. The cyclooxygenase-2 selective inhibitor, etodolac, but not aspirin reduces neovascularization in a murine ischemic hind limb model.
     Eur J Pharmacol, 627(1): 223-8. [Abstract] [Full-text]
176. Regeneration of periodontal tissue: bone replacement grafts.
     Dent Clin North Am, 54(1): 55-71. [Abstract] [Full-text]
177. Sustained seroconversion of chronic hepatitis B infection after stem cell transplantation.
     Pediatr Transplant. [Abstract] [Full-text]
178. Interleukin-10 Delivery Via Mesenchymal Stem Cells: A Novel Gene Therapy Approach To Prevent Lung Ischemia-Reperfusion Injury.
     Hum Gene Ther. [Abstract] [Full-text]
179. Distributions of HLA-A and -B alleles and haplotypes in the Yi ethnic minority of Yunnan, China: relationship to other populations.
     J Zhejiang Univ Sci B, 11(2): 127-35. [Abstract] [Full-text]
180. Human cord blood stem cells enhance neonatal right ventricular function in an ovine model of right ventricular training.
     Ann Thorac Surg, 89(2): 585-93, 593.e1-4. [Abstract] [Full-text]
181. Neurotrophic regulation of fibroblast dedifferentiation during limb skeletal regeneration in the axolotl (Ambystoma mexicanum).
     Dev Biol, 337(2): 444-57. [Abstract] [Full-text]
182. Rejuvenation of the inflammatory system stimulates fracture repair in aged mice.
     J Orthop Res. [Abstract] [Full-text]
183. Secondary alveolar bone grafting (CLEFTSiS) 2000-2004.
     Cleft Palate Craniofac J, 47(1): 66-72. [Abstract] [Full-text]
184. Restorative approaches in Parkinson's Disease: which cell type wins the race?
     J Neurol Sci, 289(1): 93-103. [Abstract] [Full-text]
185. Composite cartilage island grafts in type 1 tympanoplasty: audiological and otological outcomes.
     J Craniofac Surg, 21(1): 37-9. [Abstract] [Full-text]
186. Comparative evaluation of autogenous calvarial bone graft and alloplastic materials for secondary reconstruction of cranial defects.
     J Craniofac Surg, 21(1): 79-82. [Abstract] [Full-text]
187. Late-term results of tissue-engineered vascular grafts in humans.
     J Thorac Cardiovasc Surg, 139(2): 431-6, 436.e1-2. [Abstract] [Full-text]
188. Cell fusion of bone marrow cells and somatic cell reprogramming by embryonic stem cells.
     FASEB J, 24(2): 364-73. [Abstract] [Full-text]
189. Induction of nitric oxide by erythropoietin is mediated by the {beta} common receptor and requires interaction with VEGF receptor 2.
     Blood, 115(4): 896-905. [Abstract] [Full-text]
190. Engineering human cell-based, functionally integrated osteochondral grafts by biological bonding of engineered cartilage tissues to bony scaffolds.
     Biomaterials, 31(8): 2252-9. [Abstract] [Full-text]
191. Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors.
     Nature, 463(7280): 501-6. [Abstract] [Full-text]
192. Isolation of pig bone marrow mesenchymal stem cells suitable for one-step procedures in chondrogenic regeneration.
     J Tissue Eng Regen Med. [Abstract] [Full-text]
193. Bone Marrow Transplantation Temporarily Improves Pancreatic Function in Streptozotocin-Induced Diabetes: Potential Involvement of Very Small Embryonic-Like Cells.
     Transplantation. [Abstract] [Full-text]
194. Tissue type plasminogen activator regulates myeloid-cell dependent neoangiogenesis during tissue regeneration.
     Blood. [Abstract] [Full-text]
195. Transplant outcomes for primary immunodeficiency disease.
     Semin Hematol, 47(1): 79-85. [Abstract] [Full-text]
196. Transplant outcomes in mucopolysaccharidoses.
     Semin Hematol, 47(1): 59-69. [Abstract] [Full-text]
197. Transplant outcomes in acute leukemia. I.
     Semin Hematol, 47(1): 46-50. [Abstract] [Full-text]
198. Transplant outcomes in bone marrow failure syndromes and hemoglobinopathies.
     Semin Hematol, 47(1): 37-45. [Abstract] [Full-text]
199. Unrelated umbilical cord blood transplantation and immune reconstitution.
     Semin Hematol, 47(1): 22-36. [Abstract] [Full-text]
200. Antibiotic Modification of Native Bone Grafts: Improving Upon Nature's Scaffolds.
     Tissue Eng Part A. [Abstract] [Full-text]
201. The repair of large segmental bone defects in the rabbit with vascularized tissue engineered bone.
     Biomaterials, 31(6): 1171-9. [Abstract] [Full-text]
202. The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation.
     Biomaterials, 31(6): 1242-50. [Abstract] [Full-text]
203. Immunological response to tissue-engineered cartilage derived from auricular chondrocytes and a PLLA scaffold in transgenic mice.
     Biomaterials, 31(6): 1227-34. [Abstract] [Full-text]
204. Small intestine submucosa sponge for in vivo support of tissue-engineered bone formation in the presence of rat bone marrow stem cells.
     Biomaterials, 31(6): 1104-13. [Abstract] [Full-text]

© 2004-2010 Bone Grafts Research Today. All Rights Reserved.